Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic …
IV Maev, AA Samsonov, LK Palgova… - BMJ open …, 2020 - bmjopengastro.bmj.com
Objective Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal
results of liver function tests. Earlier research showed that polyenylphosphatidylcholine …
results of liver function tests. Earlier research showed that polyenylphosphatidylcholine …
[HTML][HTML] Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER …
IV Maev, AA Samsonov, LK Palgova… - BMJ Open …, 2020 - bmjopengastro.bmj.com
Objective The concept of using naturally occurring compounds such as
polyenylphosphatidylcholine (PPC) as an adjunctive therapy to treat non-alcoholic fatty liver …
polyenylphosphatidylcholine (PPC) as an adjunctive therapy to treat non-alcoholic fatty liver …
[HTML][HTML] A new, non-invasive scale for steatosis developed using real-world data from Russian outpatients to aid in the diagnosis of non-alcoholic fatty liver disease
IV Maev, AA Samsonov, LB Lazebnik… - Advances in …, 2020 - Springer
Introduction The current non-invasive tools for the diagnosis of non-alcoholic fatty liver
disease (NAFLD) have methodological limitations. We aimed to develop a non-invasive …
disease (NAFLD) have methodological limitations. We aimed to develop a non-invasive …
Gastroesophageal reflux disease in the practice of the therapist of the polyclinic: terra incognita
EI Vovk, LV Sediakina, MM Shamuilova… - Consilium …, 2020 - journals.eco-vector.com
Gastroesophageal reflux disease is one of the most common nosological forms in
gastroenterology. The lecture sheds light on the pathogenesis of the disease, examines …
gastroenterology. The lecture sheds light on the pathogenesis of the disease, examines …